The unique macroeconomical framework should help the Italian manufacturers of pharmaceutical raw materials to strengthen their leading position in the field. Investments and institutional support is needed to overcome the bottlenecks that still slow down foreign investments in Italy. The president of Aschimfarma Gian Mario Baccalini comments the current trends.
